Pharmaceutical Engineering & Drug Delivery

Quality by Design for Generic Drugs: Overview

Conference Presentation
AIChE Annual Meeting
Sunday, November 7, 2010 - 7:00pm
Quality by design is an essential part of the modern approach to pharmaceutical quality. But there is uncertainty in the generic drug industry about...

Quality by Design in Pharmaceutical Development

Conference Presentation
AIChE Annual Meeting
Sunday, November 7, 2010 - 7:00pm
More than 70% of the prescriptions in the US are now filled with generic products, and therefore, the industry has the responsibility to continue to...

Application of Modeling to Scale-up Liquid Mixing Processes

Conference Presentation
AIChE Annual Meeting
Wednesday, November 11, 2009 - 7:00pm
Scale-up of liquid mixing is usually done empirically without considering the several factors like dissolution theory, equipment differences between...

Drug Product Quality by Design: An Industrial Perspective

Conference Presentation
AIChE Annual Meeting
Sunday, November 8, 2009 - 7:00pm
The regulatory quality guidances (Q8 – Q10) have set the expectation to develop pharmaceutical products based on a comprehensive quality by design...

Application of QbD Principles to Analytical Methods

Conference Presentation
AIChE Annual Meeting
Sunday, November 8, 2009 - 7:00pm
The same QbD Principles applied to the design of manufacturing processes are applicable to the design of analytical methodology. QbD elements such as...

Update on QbD Implementation: An FDA Perspective

Conference Presentation
AIChE Annual Meeting
Sunday, November 8, 2009 - 7:00pm
Quality by Design (QbD) is a science and risk based approach for pharmaceutical process development and manufacturing that begins with first defining...

CEP: News Update

December
2014
News Update
Fossil Fuels Inspire Clean-Hydrogen Catalyst; Organic Solar Cells Heat Up; Biomass Waste Gets Upgraded; New Technique Puts Catalysts on the Right Track; and more.

CEP: News Update

November
2014
News Update
AIChE’s Initial Placement Survey: Where is the Class of 2014?; Producing More Ethanol with Less-Sensitive Microbes; Stretchable Patch Provides First-Class Health Monitoring; New Drug Capsule Takes the Ouch Out of Injections; Hybrid Device Combines a Solar Cell and a Battery.

CEP: News Update

July
2014
News Update
Nanoparticles Detect Sulfur Content in Crude Oil; Putting Waste Heat to Work; New Process Prints Personalized Drugs; EPA to Cut CO2 from Power Plants; Microbes Convert Biodiesel Waste into Valuable Chemicals

CEP: News Update

March
2014
News Update
Silicon Anode Gets a Fruity Makeover; New Anode Provides a Home for Plus-Sized Na+ Ions; A Flicker of Hope for Nonflammable Li-Ion Batteries; Bio-Inspired Glass Is Bendable; and more.

Bioactive Devices: Uniting Form with Function

March
2013
SBE Special Section
Sujata Bhatia
Bioactive implants that combine a medical device with one or more biologic therapeutic agents show promise for the targeted treatment of complex medical conditions. Implantable medical devices, such as stents, grafts, and joint replacements, are...

SBE Update: Drug Delivery and Chemical/Biological Engineering

March
2013
SBE Special Section
June Wispelwey
Although you might not associate drug delivery with chemical engineering, the principles of chemical engineering — such as mass and energy balances, transport phenomena, reaction kinetics, and particle technology — are intimately involved in drug...

Introduction to Drug Delivery Technology

March
2013
SBE Special Section
John T. Santini, Jr.
Drugs can be administered by many routes, yet all emerging drug delivery technologies aim to improve drug efficacy, minimize side effects, and reduce the burden of care for patients and physicians.

Engineering Biodegradable Nanoparticles for Drug and Gene Delivery

March
2013
SBE Special Section
W. Mark Saltzman, Junwei Zhang
Engineered nanoparticles can deliver therapeutic agents to specifically targeted cells and then release those agents in a precisely controlled manner. Improved pharmacokinetic properties, reduced toxicity, and the ability to cross biological barriers are some of the key benefits of this approach.

The Blood-Brain Barrier and Drug Delivery

March
2013
SBE Special Section
William Olbricht
To maintain favorable conditions in the brain, the blood-brain barrier limits mass transfer across brain tissue. However, it also restricts the systemic delivery of compounds to treat neurological disorders. Several treatment alternatives to bypass...

Chemical Engineering in the Pharmaceutical Industry: R&D to Manufacturing

October, 2010
This book deals with various unique elements in the drug development process within chemical engineering science and pharmaceutical R&D. The book is intended to be used as a professional reference and potentially as a text book reference in pharmaceutical engineering and pharmaceutical sciences...
Subscribe to Pharmaceutical Engineering & Drug Delivery